Few advanced technologies missed out in exemption list, MTal

Pavan Choudary, Chairman, Medical Technology Association of India (MTaI), said, “The guiding principle behind GTE exemptions has been to ensure patient access to medical technologies that are not yet adequately manufactured in India. Many MTaI members manufacture in India and strongly support the growth of domestic manufacturing. MTaI believes, products that are available locally in sufficient quantities and at the required quality standards can be procured domestically. However, where advanced technologies are not manufactured in India, or domestic capacity is insufficient to meet clinical needs, continued GTE exemptions remain essential.”

“While the 2024 exercise was largely comprehensive, a few advanced technologies that are not manufactured in India were missed out in the exemption list. We welcome the current review and hope it results in a complete, evidence-based framework that accurately reflects manufacturing realities and patient needs.”

“Any exclusion of technologies that are not adequately available in India risks limiting patient access to critical medical innovations and could adversely affect healthcare outcomes,” he added.
MB Bureau